ASCO Posters Detail Results from ALLO-501 ALPHA and ALLO-501A ALPHA2 Trials in Non-Hodgkin Lymphoma and Safety and PK/PD Data of...
Personalized Therapy Biosimulation Predicts with 100% Accuracy ATRA Non-Response in AML Patients with Favorable Genomic FeaturesSOUTH SAN FRANCISCO, Calif., June...
Personalized Therapy Biosimulation Using Multi-Omic Data Predicts OS and PFS for NSCLC PatientsSOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE...
Personalized Therapy Biosimulation Using Multi-Omic Data Accurately Predicts Clinical Outcomes for GBM PatientsSOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE...
LONDON, United Kingdom, June 04, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision...
The ongoing dose escalation Phase 1/2a trial has enrolled 89 patients with progressive, metastatic castration-resistant prostate cancer in 13 cohorts.Safety...
IMV Share Price Source: Yahoo Finance Comparison of IMV Share Price Source: Yahoo Finance Concerned Shareholder has been contacted by...
PRAGUE, Czech Republic, June 04, 2021 (GLOBE NEWSWIRE) -- SOTIO, a clinical stage immune-oncology company owned by PPF Group, today...
Partnership aims to leverage spatial biology data, generated on Akoya’s Phenoptics™ platform, to inform and guide drug development programsMARLBOROUGH, Mass.,...
CHARLOTTE, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), today announced that it has...
Data highlights in vitro and in vivo activity of KIN-2787 against human cancers driven by Class I, Class II and...
Cyclerion eligible to receive up to $585 million in potential future development and commercial milestone payments, and tiered sales-based royalties...
IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today...